메뉴 건너뛰기




Volumn 35, Issue 2, 2005, Pages 90-92

Stability of flucloxacillin in elastomeric infusion devices

Author keywords

[No Author keywords available]

Indexed keywords

ELASTOMER; FLUCLOXACILLIN;

EID: 23444451417     PISSN: 1445937X     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.2055-2335.2005.tb00313.x     Document Type: Article
Times cited : (9)

References (8)
  • 1
    • 0033949385 scopus 로고    scopus 로고
    • Pharmacoeconomic considerations in the ambulatory use of parenteral cephalosporins
    • Tice AD. Pharmacoeconomic considerations in the ambulatory use of parenteral cephalosporins. Drugs 2000; 59 (suppl. 3): S29-S35.
    • (2000) Drugs , vol.59 , Issue.SUPPL. 3
    • Tice, A.D.1
  • 2
    • 33644563471 scopus 로고    scopus 로고
    • Drugs in ambulatory infusion devices. The appropriate temperature for stability
    • Poole SG, Dooley MJ. Drugs in ambulatory infusion devices. The appropriate temperature for stability. Aust J Hosp Pharm 1999; 29: 328-9.
    • (1999) Aust J Hosp Pharm , vol.29 , pp. 328-329
    • Poole, S.G.1    Dooley, M.J.2
  • 3
    • 0032926416 scopus 로고    scopus 로고
    • The clinical efficacy of continuous-infusion flucloxacillin in serious staphylococcal sepsis
    • Leder K, Turnidge JD, Korman TM, Grayson ML. The clinical efficacy of continuous-infusion flucloxacillin in serious staphylococcal sepsis. J Antimicrob Chemother 1999; 43: 113-8.
    • (1999) J Antimicrob Chemother , vol.43 , pp. 113-118
    • Leder, K.1    Turnidge, J.D.2    Korman, T.M.3    Grayson, M.L.4
  • 5
  • 6
    • 0031867150 scopus 로고    scopus 로고
    • Stability of flucloxacillin in a hospital in the home program
    • To TP, Garrett MK. Stability of flucloxacillin in a hospital in the home program [letter]. Aust J Hosp Pharm 1998; 28: 289-90.
    • (1998) Aust J Hosp Pharm , vol.28 , pp. 289-290
    • To, T.P.1    Garrett, M.K.2
  • 8
    • 0028799290 scopus 로고
    • Practical aspects of the stability testing of formulated drug products
    • Prankerd R. Practical aspects of the stability testing of formulated drug products. Aust J Hosp Pharm 1995; 25: 405-8.
    • (1995) Aust J Hosp Pharm , vol.25 , pp. 405-408
    • Prankerd, R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.